A quick and easy new blood-type test is near the end of its journey from high-tech Australian laboratories to the market.

The technology – known as ‘GLIF’ - enables 1-minute blood typing without the need for laboratory equipment, expertise or interpretation of results.

In a matter of seconds a written result is returned to the user, who could be anyone, anywhere.

The applications are as broad as they are exciting, with people in third world countries, multi-trauma events, and countries with heavy conflict to be of most benefit.

GLIF uses low cost materials (paper), low cost manufacturing, and patented techniques of sample dispersion to perform a safe, reliable and fast ABO test, presenting the result in legible text for a quick and clear result.

It is the result of a between Monash University and bio-tech firm Haemokinesis, with funding provided by the Australian Research Council (ARC) under the criteria of a Linkage project.

“This product is cheaper, simpler, faster and more effective than the current process of determining someone's blood group which involves a laboratory, test tube testing, multiple people and manual labour in addition to the end result which can take days to access,” says Professor Gil Garnier, Director of Australian Pulp & Paper Institute at Monash University.

“GLIF relieves all of these elements requiring just one user to perform the test and read the results.”

Jim Manolios, CEO of Haemokinesis, said, “The vision and commitment of our teams has enabled us to bring GLIF to the market.”

“An Australian made and licensed world changing product, formed through a long standing collaboration that we are extremely passionate about – just wait and see what comes next.”

GLIF can be seen in action below.